Schroeter H, Heiss C, Balzer J, Kleinbongard P, Keen CL, Hollenberg NK, Sies H, Kwik-Uribe C, Schmitz HH, Kelm M
The medication resmetirom (Rezdiffra) is FDA-approved for certain people with MASH who do not have cirrhosis but do have fibrosis
If additional effect is needed after four weeks at 5mg, the dose escalates to 7.5mg weekly for four weeks, then to 10mg weekly, 12.5mg weekly, and finally 15mg weekly if required
This could include nausea, vomiting, diarrhoea, constipation
Nurse: Well, now were down to 4 because were almost done
Hanley team, the outcome shows a reduced mortality of IVH patients after alteplase treatment, but does not improve the secondary neurological dysfunction significantly (Hanley et al., 2017)